We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$8.39M
APM
2
Avidity Partners Management
Texas
$6.25M +$438K +117,108 +8%
AG
3
Artal Group
Luxembourg
$5.83M
CA
4
CHI Advisors
New York
$5.12M +$1.99M +531,914 +69%
FP
5
Flagship Pioneering
Massachusetts
$3.93M
SB
6
Samsara BioCapital
California
$3.48M
DTC
7
Deep Track Capital
Connecticut
$3.27M +$3.1M +828,485 New
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$2.85M
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.09M +$116K +30,984 +6%
DCM
10
DAFNA Capital Management
California
$1.05M
OFM
11
Omega Fund Management
Massachusetts
$993K
BlackRock
12
BlackRock
New York
$971K +$130K +34,681 +16%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$545K +$29.9K +8,002 +6%
ECM
14
ExodusPoint Capital Management
New York
$427K -$38.4K -10,261 -9%
Goldman Sachs
15
Goldman Sachs
New York
$421K +$4.16K +1,111 +1%
DMKJ
16
David M. Knott Jr
$419K +$36.4K +9,715 +10%
LPL Financial
17
LPL Financial
California
$356K -$14.6K -3,900 -4%
LCP
18
LGT Capital Partners
Switzerland
$217K
Renaissance Technologies
19
Renaissance Technologies
New York
$194K +$11.6K +3,100 +7%
BCM
20
Bridgeway Capital Management
Texas
$156K
State Street
21
State Street
Massachusetts
$131K
Corient Private Wealth
22
Corient Private Wealth
Florida
$105K
Northern Trust
23
Northern Trust
Illinois
$104K +$21.2K +5,667 +27%
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$99.3K +$55.2K +14,754 +142%
SC
25
Shay Capital
New York
$93.9K -$9.91K -2,650 -10%